Management of dyslipidemia in pediatric renal transplant recipients

被引：0
作者：
Margret E. Bock
Leslie Wall
Carly Dobrec
Mary Chandran
Jens Goebel
机构：
[1] University of Colorado,Section of Pediatric Nephrology, Children’s Hospital Colorado
[2] Children’s Hospital Colorado,Clinical Nutrition Department
[3] University of Colorado,Pharmacy Department, Children’s Hospital Colorado
来源：
Pediatric Nephrology | 2021年 / 36卷
关键词：
Dyslipidemia; Transplant; Pediatric; Kidney; Cholesterol; Triglycerides;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dyslipidemia after kidney transplantation is a common complication that has historically been underappreciated, especially in pediatric recipients. It is also a major modifiable risk factor for cardiovascular disease, a top cause of morbidity and mortality of transplant patients. While most knowledge about post-transplant dyslipidemia has been generated in adults, recommendations and treatment strategies also exist for children and are presented in this review. Awareness of these applicable guidelines and approaches is required, but not sufficient, for the reliable management of dyslipidemia in our patients, and additional needs and opportunities for comprehensive care in this area (e.g., quality improvement) are outlined.
引用
收藏
页码：51 / 63
页数：12
相关论文
共 444 条
  • [1] Parekh RS(2002)Cardiovascular mortality in children and young adults with end-stage kidney disease J Pediatr 141 191-197
  • [2] Carroll CE(2019)Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Circulation 139 e603-e634
  • [3] Wolfe RA(2015)Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease Clin Nephrol 83 262-271
  • [4] Port FK(2019)Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies Nephrol Dial Transplant 34 760-773
  • [5] de Ferranti SD(2011)Change in mortality risk over time in young kidney transplant recipients Am J Transplant 11 2432-2442
  • [6] Steinberger J(2016)The Renal Transplant Patient – Updates for the Pediatrician Curr Treat Options Pediatr 26 233-240
  • [7] Ameduri R(2011)Expert Panel on Integrated Guidelines for Cardiovascular health and risk reduction in children and adolescents summary report Pediatrics 128 S213-S256
  • [8] Baker A(2010)High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients Pediatr Transplant 14 52-60
  • [9] Gooding H(2013)The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study Pediatr Nephrol 28 939-949
  • [10] Kelly AS(2013)Reliable individualized monitoring improves cholesterol control in kidney transplant recipients Pediatrics 131 e1271-e1279
12345678910